EU TRANSPARENCY REGISTER · 6511761101113-89 · France

Osivax

Category

Companies & groups

Country

France

PARIS

Entity form

SAS

Stated objectives

Osivax is a European clinical-stage biotechnology company pioneering universal influenza vaccine development through a groundbreaking T-cell-targeted approach. Our flagship vaccine candidate, OVX836, represents a paradigm shift in influenza…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2025-10-29

Other Companies & groups in France

Other registered organisations in France

Frequently asked questions

What is this organisation?
Osivax is an interest representative listed in the EU Joint Transparency Register under ID 6511761101113-89. Entity form: SAS.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in France, PARIS.
What are its stated goals?
As declared by the registrant: Osivax is a European clinical-stage biotechnology company pioneering universal influenza vaccine development through a groundbreaking T-cell-targeted approach. Our flagship vaccine candidate, OVX836, represents a paradigm shift in influenza…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 6511761101113-89.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-08 · Commission Reuse Decision 2011/833/EU